Pralsetinib-induced interstitial pneumonitis in a patient with metastatic pulmonary sarcomatoid carcinoma harboring RET fusion: a case report. (PubMed, AME Case Rep) - Oct 15, 2026 - "However, its risk of severe interstitial pneumonitis highlights the need for close monitoring. Clinicians should balance risks and benefits, especially for rechallenge, to optimize outcomes."
Journal • Interstitial Lung Disease • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Pneumonia • Sarcoma • Solid Tumor • KIF5B • RET
|
|
Jie Huang; Jing Zhang; Jingjing Xiang; Shenglin Ma; Xin Li; Xueqin Chen; Yao Qiu
|